lomeguatrib and Glioma

lomeguatrib has been researched along with Glioma* in 1 studies

Other Studies

1 other study(ies) available for lomeguatrib and Glioma

Article	Year
Preparation of PEGylated liposomes incorporating lipophilic lomeguatrib derivatives for the sensitization of chemo-resistant gliomas. International journal of pharmaceutics, 2018, Jan-30, Volume: 536, Issue:1 Liposomal delivery is a well-established approach to increase the therapeutic index of drugs, mainly in the field of cancer chemotherapy. Here, we report the preparation and characterization of a new liposomal formulation of a derivative of lomeguatrib, a potent O Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioma; Guanine; Humans; Liposomes; Mice; Polyethylene Glycols; Purines	2018

Article

Year

Preparation of PEGylated liposomes incorporating lipophilic lomeguatrib derivatives for the sensitization of chemo-resistant gliomas.

International journal of pharmaceutics, 2018, Jan-30, Volume: 536, Issue:1

Liposomal delivery is a well-established approach to increase the therapeutic index of drugs, mainly in the field of cancer chemotherapy. Here, we report the preparation and characterization of a new liposomal formulation of a derivative of lomeguatrib, a potent O

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioma; Guanine; Humans; Liposomes; Mice; Polyethylene Glycols; Purines

2018